Alphatec Holdings, Inc.
ATECNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $764.2M | $611.6M | $482.3M | $350.9M | $243.2M | $144.9M |
| Operating income | −$82.1M | −$136.2M | −$173.4M | −$147.0M | −$128.1M | −$58.9M |
| Net income | −$143.4M | −$162.1M | −$186.6M | −$151.3M | −$144.3M | −$79.0M |
| Total assets | $791.2M | $775.7M | $805.2M | $521.0M | $572.1M | $261.2M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $12.4M | −$14.2M | $78.1M | −$34.7M | $79.4M | $129.9M |
| EPS (diluted) | $-0.96 | $-1.13 | $-1.54 | $-1.46 | $-1.49 | $-1.18 |
| Shares out. | 144.1M | 138.0M | 111.1M | 99.8M | 95.1M | 63.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −10.7%
- Net margin
- −18.8%
- Return on equity
- −1153.7%
- Return on assets
- −18.1%
- Return on capital (ROCE)
- −14.4%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.09
- Revenue growth (YoY)
- 25.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −23.8%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 2, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Squadron Capital LlcActivist (13D)Dec 17, 2025
- L-5 Healthcare Partners, LlcActivist (13D)Apr 23, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Valentine KeithDirector | May 7, 2026 | Buy | 56,153 | $7.49 |
| Marshall Tyson EliotOfficer — GENERAL COUNSEL & CORP. SEC. | Apr 7, 2026 | Option exercise | 15,000 | $1.98 |
| Koning John ToddOfficer — CHIEF FINANCIAL OFFICER | Mar 13, 2026 | Sell | 79,789 | $12.36 |
| Lish ScottOfficer — CHIEF OPERATING OFFICER | Mar 13, 2026 | Sell | 260,535 | $12.30 |
| Sponsel DavidOfficer — EVP, SALES | Mar 11, 2026 | Sell | 163,452 | $12.52 |
| Hunsaker Craig EOfficer — EVP, PEOPLE & CULTURE | Mar 6, 2026 | Sell | 33,602 | $12.22 |
| Koning John ToddOfficer — CHIEF FINANCIAL OFFICER | Mar 5, 2026 | Tax withholding | 68,910 | $12.57 |
| Miles PatrickOfficer — CEO | Mar 5, 2026 | Tax withholding | 219,749 | $12.57 |
| Marshall Tyson EliotOfficer — GENERAL COUNSEL & CORP. SEC. | Mar 5, 2026 | Sell | 88,835 | $12.49 |
| Marshall Tyson EliotOfficer — GENERAL COUNSEL & CORP. SEC. | Feb 25, 2026 | Grant | 205,094 | $0.00 |
| Sponsel DavidOfficer — EVP, SALES | Feb 25, 2026 | Grant | 205,094 | $0.00 |
| Koning John ToddOfficer — CHIEF FINANCIAL OFFICER | Feb 25, 2026 | Grant | 205,094 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 14.2M | 2.2 | +18.9% |
| Apr 30, 2026 | 11.9M | 4.1 | -15.2% |
| Apr 15, 2026 | 14.0M | 6.5 | -6.0% |
| Mar 31, 2026 | 14.9M | 7.0 | -2.4% |
| Mar 13, 2026 | 15.3M | 6.0 | +11.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Results of operations · New financial obligationMay 5, 2026
- Director / officer change · Other material eventMar 3, 2026
- Results of operationsFeb 24, 2026
- Results of operationsJan 12, 2026
- Other material eventNov 7, 2025
- Results of operationsOct 30, 2025
- Results of operationsJul 31, 2025
- Amended charter or bylaws · Shareholder voteJun 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.